Contribution of Macrophage Migration Inhibitory Factor -173G/C Gene Polymorphism to the Risk of Cancer in Chinese Population |
Wang, Cheng-Di
(Department of Respiratory Medicine, West China Hospital, Sichuan University)
Li, Tai-Ming (Department of Pediatric Surgery, West China Hospital, Sichuan University) Ren, Zheng-Ju (Department of Urology, West China Hospital, Sichuan University) Ji, Yu-Lin (Department of Respiratory Medicine, West China Hospital, Sichuan University) Zhi, Liu-Shou (Department of Respiratory Medicine, West China Hospital, Sichuan University) |
1 | Du JZ, Dong YL, Wan GX, et al (2014). Lack of Association between the COMT rs4680 polymorphism and ovarian cancer risk: evidence from a meta-analysis of 3,940 individuals. Asian Pac J Cancer Prev, 15, 7941-5. DOI |
2 | Gu S, Wu Q, Zhao X, et al (2012). Association of CASP3 polymorphism with hematologic toxicity in patients with advanced non-small-cell lung carcinoma treated with platinum-based chemotherapy. Cancer Sci, 103, 1451-59. DOI |
3 | Li H, Zang J, Wang P, et al (2012). Gastric cancer susceptibility in gastric cancer relatives: attributable risks of Macrophage migration inhibitory factor promoter polymorphism and Helicobacter pylori. Cytokine, 60, 346-351. DOI |
4 | Meyer-Siegler KL, Bellino MA, Tannenbaum M (2002). Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma. Cancer, 94, 1449-56. DOI |
5 | Meyer-Siegler KL, Iczkowski KA, Vera PL (2005). Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer. BMC cancer, 5, 73. DOI |
6 | Meyer-Siegler KL, Vera PL, Iczkowski KA, et al (2007). Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence. Genes and immunity, 8, 646-52. DOI |
7 | Ramireddy L, Chen WT, Peng CT, et al (2014). Association Between Genetic Polymorphism of the MIF Gene and Colorectal Cancer in Taiwan. J Clin Lab Anal, 00, 1-7 |
8 | Ramireddy L, Lin CY, Liu SC, et al (2014). Association study between macrophage migration inhibitory factor-173 polymorphism and acute myeloid leukemia in Taiwan. Cell Biochem Biophys, 70, 1159-65. DOI |
9 | Rendon BE, Roger T, Teneng I, et al (2007): Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J Biol Chem, 282, 29910-8. DOI |
10 | Tong X, He J, Liu S, et al (2015). Macrophage migration inhibitory factor -173G/C gene polymorphism increases the risk of renal disease: a meta-analysis. Nephrology, 20, 68-76 DOI |
11 | Vera PL, Meyer-Siegler K L (2011). Association between macrophage migration inhibitory factor promoter region polymorphism (-173 G/C) and cancer: a meta-analysis. BMC Res Notes, 4, 395 DOI |
12 | Verjans E, Noetzel E, Bektas N, e al (2009). Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer. BMC cancer, 9, 230. DOI |
13 | Wu S, Lian J, Tao H, et al (2011). Correlation of macrophage migration inhibitory factor gene polymorphism with the risk of early-stage cervical cancer and lymphatic metastasis. Oncol Lett, 2, 1261-67. DOI |
14 | Xue Y, Xu H, Rong L, et al (2010). The MIF -173G/C polymorphism and risk of childhood acute lymphoblastic leukemia in a Chinese population. Leuk Res, 34, 1282-86. DOI |
15 | Yang HY, Yang SY, Shao FY, et al (2015). Updated assessment of the association of the XRCC1 Arg399Gln Polymorphism with lung cancer risk in the Chinese population. Asian Pac J Cancer Prev, 16, 495-500. DOI |
16 | Yuan Q, Wang M, Zhang Z, et al (2012). Macrophage migration inhibitory factor gene -173G>C polymorphism and risk of bladder cancer in southeast China: a case-control analysis. Mol Biol Rep, 39, 3109-15. DOI |
17 | Yuan T, Tang C, Chen M, et al (2013). Influence of the human MIF promoter polymorphism on hepatocellular carcinoma prognosis. Genetics and Molecular Research, 12, 6629-35 DOI |
18 | Balkwill F, Mantovani A (2010). Cancer and inflammation: implications for pharmacology and therapeutics. Clin Pharmacol Ther, 87, 401-6. DOI |
19 | Arisawa T, Tahara T, Shibata T, et al (2008). Functional promoter polymorphisms of the macrophage migration inhibitory factor gene in gastric carcinogenesis. Oncology reports, 19, 223-8. |
20 | Babu SN, Chetal G, Kumar S (2012). Macrophage migration inhibitory factor: A potential marker for cancer diagnosis and therapy. Asian Pac J Cancer Prev, 13, 1737-44. DOI ScienceOn |
21 | Bloom BR, Bennett B (1966). Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science, 153, 80-2. DOI |
22 | Chen W, Zheng R, Zeng H, Zhang S, et al (2015). Annual report on status of cancer in China, 2011. Chin J Cancer Res, 27, 2-12 |
23 | De Benedetti F, Cristina M, Vivarelli M, et al (2003). Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum, 48, 1398-407. DOI |
24 | Ding GX, Zhou SQ, Xu Z, et al (2009). The association between MIF-173 G>C polymorphism and prostate cancer in southern Chinese. J Surg Oncol, 100, 106-110. DOI |
25 | Ziino O, D'Urbano LE, Benedetti FD, et al (2005). The MIF-173G/C polymorphism does not contribute to prednisone poor response in vivo in childhood acute lymphoblastic leukemia. Leukemia, 19, 2346-7. DOI |
26 | Zheng CL, Qiu C, Shen MX, et al (2015). Prognostic impact of elevation of vascular endothelial growth factor family expression in patients with non-small cell lung cancer: an updated meta-analysis. Asian Pac J Cancer Prev, 16, 1881-95 DOI |
27 | Zhu LX, Ho SC, Wong TK (2013). Effectiveness of health education programs on exercise behavior among patients with heart disease: a systematic review and meta-analysis. J Evid Based Med, 6, 265-301. DOI |